Autonomix Medical (NASDAQ:AMIX – Get Free Report) released its quarterly earnings data on Wednesday. The company reported $0.09 earnings per share for the quarter, FiscalAI reports.
Autonomix Medical Price Performance
Autonomix Medical stock opened at $0.42 on Thursday. The firm has a market capitalization of $2.88 million, a price-to-earnings ratio of -0.12 and a beta of -1.82. The company’s 50 day simple moving average is $0.38 and its 200 day simple moving average is $0.52. Autonomix Medical has a fifty-two week low of $0.20 and a fifty-two week high of $2.64.
Analysts Set New Price Targets
AMIX has been the topic of several recent analyst reports. Weiss Ratings raised shares of Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research note on Monday, May 18th. Maxim Group reduced their price objective on shares of Autonomix Medical from $5.00 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $2.00.
Autonomix Medical Company Profile
Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Featured Stories
- Five stocks we like better than Autonomix Medical
- Bath & Body Works Stock Surged Despite Falling Sales—Here’s Why
- Dick’s Sporting Goods Isn’t Done Winning Yet
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.
